한글목차

세계 생물제제용 API 제조 서비스 시장 규모는 2033년까지 연평균 11.6%의 성장률을 보일 것으로 예상됩니다.

다양한 질병과의 싸움에서 API의 역동적인 역할

API(의약품 유효성분)는 암, 심혈관 질환, 당뇨병, 감염, 진통, 호흡기 질환 등 다양한 치료에서 중요한 역할을 하고 있습니다. 박테리아와 바이러스 감염을 표적으로 하는 의약품 개발에 큰 도움이 되어 치료 솔루션의 발전에 기여하고 있습니다.

감염병은 세계 사망의 주요 원인으로 공중보건과 경제발전에 큰 영향을 미치고 있습니다. 말라리아, 결핵과 같은 질병에서 약제 내성 균주의 출현과 살충제 내성 박테리아의 출현으로 인해 더 복잡한 의료 개입이 필요하게 되었습니다. 이러한 복잡성은 환자에게 경제적 및 건강 측면에서 지속적인 영향을 미칩니다.

이러한 질병이 세계인의 건강에 미치는 악영향, 항균제에 대한 내성 증가, 효과적인 항생제의 가용성 감소 등의 배경에서 혁신 기업들은 이러한 문제를 해결할 수 있는 새로운 치료제의 발견과 생산에 집중하고 있습니다.

전략적 제휴와 협력

제약업계의 제휴와 협력은 생물학적 제제의 API를 제조하는 CMO에 큰 성장 잠재력을 제공합니다. 제약회사, 대학, 연구센터와의 전략적 제휴를 통해 자원을 공유하고, 지식을 공유하며, 혁신을 촉진할 수 있습니다.

세계 생물제제용 API 제조 서비스 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 보고서 개요

제2장 주요 요약

제3장 시장 개요

• 주요 조사 결과
• 시장 역학
• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• SWOT 분석
• 업계 분석 : PEST 분석
• Porter의 Five Forces 분석
• COVID-19의 영향 분석

제4장 생물제제용 API 제조 서비스 시장 분석 : 제조 유형별

• 주요 조사 결과
• 시장의 매력 지수
• 시장 규모 추이와 예측
• 아웃소싱
• 사내 제조
  • 시장 규모 추이와 예측 : 지역별
  • 시장 점유율 : 지역별

제5장 생물제제용 API 제조 서비스 시장 분석 : 용도별

• 주요 조사 결과
• 시장의 매력 지수
• 시장 규모 추이와 예측
• 백신
• mAB
• 인슐린 유사체
• 인터페론 요법
• 인간성장호르몬
• 기타
  • 시장 규모 추이와 예측 : 지역별
  • 시장 점유율 : 지역별

제6장 생물제제용 API 제조 서비스 시장 분석 : 발현 플랫폼별

• 주요 조사 결과
• 시장의 매력 지수
• 시장 규모 추이와 예측
• 포유류 세포배양
• 미생물 발효
• 기타
  • 시장 규모 추이와 예측 : 지역별
  • 시장 점유율 : 지역별

제7장 생물제제용 API 제조 서비스 시장 분석 : 지역별

• 주요 조사 결과
• 시장 규모 추이와 예측

제8장 북미의 생물제제용 API 제조 서비스 시장 분석

제9장 유럽의 생물제제용 API 제조 서비스 시장 분석

제10장 아시아태평양의 생물제제용 API 제조 서비스 시장 분석

제11장 라틴아메리카의 생물제제용 API 제조 서비스 시장 분석

제12장 중동 및 아프리카의 생물제제용 API 제조 서비스 시장 분석

제13장 기업 개요

• AbbVie Inc.
• Lonza
• Boehringer Ingelheim International GmbH
• Catalent, Inc.
• Piramal Pharma Solutions
• Cytovance Biologics
• FUJIFILM Diosynth Biotechnologies
• Thermo Fisher Scientific Inc.
• Samsung Biologics

제14장 결론 및 추천 사항

• Visiongain의 결론
• 시장 진출기업을 위한 추천 사항

영문목차

The global Biological Drug API Manufacturing Services market is projected to grow at a CAGR of 11.6% by 2033.

“The Biological Drug API Manufacturing Services Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Dynamic Role of APIs in Combatting Various Diseases

APIs (Active Pharmaceutical Ingredients) play a crucial role in various medical treatments, including cancer, cardiovascular disease, diabetes, infectious diseases, pain relief, and respiratory conditions. They significantly aid in the development of medications targeting bacterial and viral infections, contributing to advancements in therapeutic solutions.

Infectious diseases, a leading cause of global mortality, profoundly impact public health and economic progress. The emergence of drug-resistant strains in diseases like malaria and tuberculosis, along with insecticide-resistant organisms, has led to the necessity for more intricate medical interventions. These complexities have enduring financial and health implications for patients.

Given the adverse effects of these illnesses on worldwide health, the escalating resistance to antimicrobials, and the diminishing availability of effective antibiotics, innovative businesses are compelled to focus on discovering and producing new therapeutic medications to address these challenges.

Strategic Partnerships and Collaborations

Partnerships and collaborations within the pharmaceutical industry offer CMOs producing biological drug APIs substantial growth prospects. Creating strategic partnerships with pharmaceutical companies, universities, and research centres can encourage resource sharing, knowledge sharing, and innovation.

CMOs can help partners accelerate their drug development timelines by bringing their process development, optimisation, and scale-up expertise to early-stage collaborations. In addition, access to proprietary platforms, cutting-edge technologies, and intellectual property is made possible through strategic partnerships, which improve the CMO's capabilities and broaden its range of services.

Additionally, by forming consortia or alliances with several pharmaceutical companies, CMOs can broaden their clientele, become less reliant on a single partner, and build a network for collaborative research and development. In the field of biological drug manufacturing, collaborative approaches enable the sharing of resources, knowledge, and risk in a way that benefits both parties and promotes innovation and expansion.

What Questions Should You Ask before Buying a Market Research Report?

• How is the biological drug API manufacturing services market evolving?
• What is driving and restraining the biological drug API manufacturing services market?
• How will each biological drug API manufacturing services submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each biological drug API manufacturing services submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading biological drug API manufacturing services markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the biological drug API manufacturing services projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of

biological drug API manufacturing services projects taking place now and over the next 10 years?

• Is there a greater need for product commercialisation to further scale the biological drug API manufacturing services market?
• Where is the biological drug API manufacturing services market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the biological drug API manufacturing services market today, and over the next 10 years:

• Our 261-page report provides 89 tables, 135 charts/graphs exclusively to you
• The report highlights key lucrative areas in the industry so you can target them - NOW
• It contains in-depth analysis of global, regional and national sales and growth
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the biological drug API manufacturing services market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
• You will find original analyses, with business outlooks and developments
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Manufacturing Type

• Outsourced
• In-house

Application

• Vaccines
• mABs
• Insulin Analogues
• Interferon Therapies
• Human Growth Hormones
• Others

Expression Platform

• Mammalian Cell Cultures
• Microbial Fermentations
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

• U.S
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific

• Japan
• China
• India
• Australia
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

MEA

• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Biological Drug API Manufacturing Services Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies profiled in the report:

Overall world revenue for Biological Drug API Manufacturing Services Market, 2023 to 2033 in terms of value the market will surpass US$8,000 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the “Biological Drug API Manufacturing Services Market, 2023 to 2033” report help you?

In summary, our 260+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Biological Drug API Manufacturing Services Market 2023 to 2033, with forecasts for manufacturing type, application and expression platform, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 22 key national markets - See forecasts for the Biological Drug API Manufacturing Services Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Biological Drug API Manufacturing Services Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Biological Drug API Manufacturing Services Market 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Biological Drug API Manufacturing Services Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report Include:
• 1.6 Who is This Report For?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Visiongain Reports
• 1.10 About Visiongain

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
• 3.3 Market Driving Factors
  • 3.3.1 Biological Patent Expirations to Fuel Market Growth
  • 3.3.2 Outsourcing as a Driver for Market Growth
  • 3.3.3 Growing Investments in Orphan Drugs
  • 3.3.4 Single Use Technology will Become Essential Over the Next Decade
• 3.4 Market Restraining Factors
  • 3.4.1 Manufacturing APIs for Biologics to Restrain Market Growth
  • 3.4.2 Pricing Pressure to Impede Market Growth
  • 3.4.3 Regulatory Scenarios to Restrain Market Growth
  • 3.4.4 Excessive Production is Projected to Impede Market Growth
  • 3.4.5 API Production is a Challenging Task
• 3.5 Market Opportunities
  • 3.5.1 Advancements in Bioprocessing Techniques
  • 3.5.2 Customisation and Flexibility in Manufacturing
  • 3.5.3 Strategic Partnerships and Collaborations
  • 3.5.4 Emerging Economies to Offer Lucrative Growth Opportunities
• 3.6 SWOT Analysis
  • 3.6.1 Strengths
  • 3.6.2 Weaknesses
  • 3.6.3 Opportunities
  • 3.6.4 Threats
• 3.7 Industry analysis - PEST Analysis
  • 3.7.1 Political
  • 3.7.2 Economical
  • 3.7.3 Social
  • 3.7.4 Technological
• 3.8 Porter's Five Forces Analysis
  • 3.8.1 Bargaining Power of Suppliers is Low
  • 3.8.2 Bargaining Power of Buyers is Medium
  • 3.8.3 Competitive Rivalry is High Due to Presence of Established Firms
  • 3.8.4 Threat of Substitutes is Medium
  • 3.8.5 Threat of New Entrants is Low Owing to Huge Associated Costs
• 3.9 COVID-19 Impact Analysis

4 Biological Drug API Manufacturing Services Market Analysis by Manufacturing Type

• 4.1 Key Findings
• 4.2 Manufacturing Type Segment: Market Attractiveness Index
• 4.3 Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
• 4.4 Outsourced
  • 4.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • 4.4.2 Market Share by Region, 2023 & 2033 (%)
• 4.5 In-house
  • 4.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Biological Drug API Manufacturing Services Market Analysis by Application

• 5.1 Key Findings
• 5.2 Application Segment: Market Attractiveness Index
• 5.3 Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
• 5.4 Vaccines
  • 5.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • 5.4.2 Market Share by Region, 2023 & 2033 (%)
• 5.5 mABs
  • 5.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • 5.5.2 Market Share by Region, 2023 & 2033 (%)
• 5.6 Insulin Analogues
  • 5.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • 5.6.2 Market Share by Region, 2023 & 2033 (%)
• 5.7 Interferon Therapies
  • 5.7.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • 5.7.2 Market Share by Region, 2023 & 2033 (%)
• 5.8 Human Growth Hormones
  • 5.8.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • 5.8.2 Market Share by Region, 2023 & 2033 (%)
• 5.9 Others
  • 5.9.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • 5.9.2 Market Share by Region, 2023 & 2033 (%)

6 Biological Drug API Manufacturing Services Market Analysis by Expression Platform

• 6.1 Key Findings
• 6.2 Expression Platform Segment: Market Attractiveness Index
• 6.3 Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
• 6.4 Mammalian Cell Cultures
  • 6.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • 6.4.2 Market Share by Region, 2023 & 2033 (%)
• 6.5 Microbial Fermentations
  • 6.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • 6.5.2 Market Share by Region, 2023 & 2033 (%)
• 6.6 Others
  • 6.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • 6.6.2 Market Share by Region, 2023 & 2033 (%)

7 Biological Drug API Manufacturing Services Market Analysis by Region

• 7.1 Key Findings
• 7.2 Regional Market Size Estimation and Forecast

8 North America Biological Drug API Manufacturing Services Market Analysis

• 8.1 Key Findings
• 8.2 North America Biological Drug API Manufacturing Services Market Attractiveness Index
• 8.3 North America Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
• 8.4 North America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
• 8.5 North America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
• 8.6 North America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
• 8.7 North America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
• 8.8 U.S. Biological Drug API Manufacturing Services Market Analysis
• 8.9 Canada Biological Drug API Manufacturing Services Market Analysis

9 Europe Biological Drug API Manufacturing Services Market Analysis

• 9.1 Key Findings
• 9.2 Europe Biological Drug API Manufacturing Services Market Attractiveness Index
• 9.3 Europe Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
• 9.4 Europe Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
• 9.5 Europe Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
• 9.6 Europe Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
• 9.7 Europe Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
• 9.8 Germany Biological Drug API Manufacturing Services Market Analysis
• 9.9 UK Biological Drug API Manufacturing Services Market Analysis
• 9.10 France Biological Drug API Manufacturing Services Market Analysis
• 9.11 Italy Biological Drug API Manufacturing Services Market Analysis
• 9.12 Spain Biological Drug API Manufacturing Services Market Analysis
• 9.13 Russia Biological Drug API Manufacturing Services Market Analysis
• 9.14 Rest of Europe Biological Drug API Manufacturing Services Market Analysis

10 Asia Pacific Biological Drug API Manufacturing Services Market Analysis

• 10.1 Key Findings
• 10.2 Asia Pacific Biological Drug API Manufacturing Services Market Attractiveness Index
• 10.3 Asia Pacific Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
• 10.4 Asia Pacific Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
• 10.5 Asia Pacific Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
• 10.6 Asia Pacific Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
• 10.7 Asia Pacific Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
• 10.8 Japan Biological Drug API Manufacturing Services Market Analysis
• 10.9 China Biological Drug API Manufacturing Services Market Analysis
• 10.10 India Biological Drug API Manufacturing Services Market Analysis
• 10.11 Australia Biological Drug API Manufacturing Services Market Analysis
• 10.12 South Korea Biological Drug API Manufacturing Services Market Analysis
• 10.13 South East Asia Biological Drug API Manufacturing Services Market Analysis
• 10.14 Rest of Asia Pacific Biological Drug API Manufacturing Services Market Analysis

11 Latin America Biological Drug API Manufacturing Services Market Analysis

• 11.1 Key Findings
• 11.2 Latin America Biological Drug API Manufacturing Services Market Attractiveness Index
• 11.3 Latin America Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
• 11.4 Latin America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
• 11.5 Latin America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
• 11.6 Latin America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
• 11.7 Latin America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
• 11.8 Brazil Biological Drug API Manufacturing Services Market Analysis
• 11.9 Mexico Biological Drug API Manufacturing Services Market Analysis
• 11.10 Rest of Latin America Biological Drug API Manufacturing Services Market Analysis

12 MEA Biological Drug API Manufacturing Services Market Analysis

• 12.1 Key Findings
• 12.2 MEA Biological Drug API Manufacturing Services Market Attractiveness Index
• 12.3 MEA Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
• 12.4 MEA Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
• 12.5 MEA Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
• 12.6 MEA Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
• 12.7 MEA Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
• 12.8 GCC Biological Drug API Manufacturing Services Market Analysis
• 12.9 South Africa Biological Drug API Manufacturing Services Market Analysis
• 12.10 Rest of MEA Biological Drug API Manufacturing Services Market Analysis

13 Company Profiles

• 13.1 AbbVie Inc.
  • 13.1.1 Company Snapshot
  • 13.1.2 Company Overview
  • 13.1.3 Financial Analysis
  • 13.1.4 Service Benchmarking
  • 13.1.5 Strategic Outlook
• 13.2 Lonza
  • 13.2.1 Company Snapshot
  • 13.2.2 Company Overview
  • 13.2.3 Financial Analysis
  • 13.2.4 Service Benchmarking
  • 13.2.5 Strategic Outlook
• 13.3 Boehringer Ingelheim International GmbH
  • 13.3.1 Company Snapshot
  • 13.3.2 Company Overview
  • 13.3.3 Financial Analysis
  • 13.3.4 Service Benchmarking
  • 13.3.5 Strategic Outlook
• 13.4 Catalent, Inc.
  • 13.4.1 Company Snapshot
  • 13.4.2 Company Overview
  • 13.4.3 Financial Analysis
  • 13.4.4 Service Benchmarking
  • 13.4.5 Strategic Outlook
• 13.5 Piramal Pharma Solutions
  • 13.5.1 Company Snapshot
  • 13.5.2 Company Overview
  • 13.5.3 Service Benchmarking
  • 13.5.4 Strategic Outlook
• 13.6 Cytovance Biologics
  • 13.6.1 Company Snapshot
  • 13.6.2 Company Overview
  • 13.6.3 Service Benchmarking
  • 13.6.4 Strategic Outlook
• 13.7 FUJIFILM Diosynth Biotechnologies
  • 13.7.1 Company Snapshot
  • 13.7.2 Company Overview
  • 13.7.3 Service Benchmarking
  • 13.7.4 Strategic Outlook
• 13.8 Thermo Fisher Scientific Inc.
  • 13.8.1 Company Snapshot
  • 13.8.2 Company Overview
  • 13.8.3 Financial Analysis
  • 13.8.4 Service Benchmarking
  • 13.8.5 Strategic Outlook
• 13.9 Samsung Biologics
  • 13.9.1 Company Snapshot
  • 13.9.2 Company Overview
  • 13.9.3 Service Benchmarking
  • 13.9.4 Strategic Outlook

14 Conclusion and Recommendations

• 14.1 Concluding Remarks from Visiongain
• 14.2 Recommendations for Market Players